Skip to main content
. 2023 Sep 5;24(18):13715. doi: 10.3390/ijms241813715

Figure 2.

Figure 2

Figure 2

OS differences between the LEN combined with TIT group and the LEN monotherapy. group after PSM. (A) Median OS in the LEN combined with TIT and LEN monotherapy groups. (B) Median OS in the LEN combined with TACE, LEN combined with HAIC, and LEN monotherapy groups, respectively.